In May 2021, the Centers for Medicare and Medicaid Services (CMS) Quality Measures Voting Members unanimously recommended the addition of colorectal cancer (CRC) screening to the CMS Medicaid Adult Core Set of Quality Measures for adoption in 2022. However, CMS has the latitude to reject recommendations
from the Voting Members. The proposed CMS Medicaid CRC screening quality measure should be supported because it is actionable, has alignment with other metrics, is appropriate, is feasible, and will promote equity for all people insured through CMS.
Trending
- Grail and Quest Diagnostics to offer Galleri test to US physicians (Medical Device Network)
- Why 1 GI prefers working in an academic medical center (Becker’s GI & Endoscopy)
- Adenomas Linked to Greater Risk of Colorectal Cancer, All-Cause Mortality (HCP Live)
- Stool DNA testing ‘can be performed safely’ regardless of anticoagulant, antiplatelet use (Healio)
- Physician Practice Private Equity Transactions – A Refresher (JD Supra)
- ‘Gut-on-a-chip’ promises breakthroughs in health research (National University of Singapore)
- Considerations for Prescribing GLP-1s Get More Complicated (Medscape)
- The Doctor Will See You… On Amazon: Tech Giant Expands Plans to Merge Medicine with Marketplace (PYMNTS)